Correlation Between Sonnet Biotherapeutics and Cns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Cns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Cns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Cns Pharmaceuticals, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Cns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Cns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Cns Pharmaceuticals.
Diversification Opportunities for Sonnet Biotherapeutics and Cns Pharmaceuticals
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sonnet and Cns is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Cns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cns Pharmaceuticals and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Cns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cns Pharmaceuticals has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Cns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Sonnet Biotherapeutics and Cns Pharmaceuticals
Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to under-perform the Cns Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Sonnet Biotherapeutics Holdings is 1.49 times less risky than Cns Pharmaceuticals. The stock trades about -0.52 of its potential returns per unit of risk. The Cns Pharmaceuticals is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest 14.00 in Cns Pharmaceuticals on August 27, 2024 and sell it today you would lose (2.00) from holding Cns Pharmaceuticals or give up 14.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sonnet Biotherapeutics Holding vs. Cns Pharmaceuticals
Performance |
| Timeline |
| Sonnet Biotherapeutics |
| Cns Pharmaceuticals |
Sonnet Biotherapeutics and Cns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sonnet Biotherapeutics and Cns Pharmaceuticals
The main advantage of trading using opposite Sonnet Biotherapeutics and Cns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Cns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cns Pharmaceuticals will offset losses from the drop in Cns Pharmaceuticals' long position.| Sonnet Biotherapeutics vs. ZyVersa Therapeutics | Sonnet Biotherapeutics vs. Allarity Therapeutics | Sonnet Biotherapeutics vs. Immix Biopharma | Sonnet Biotherapeutics vs. Cns Pharmaceuticals |
| Cns Pharmaceuticals vs. Capricor Therapeutics | Cns Pharmaceuticals vs. Soleno Therapeutics | Cns Pharmaceuticals vs. Bio Path Holdings | Cns Pharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |